The following resources and publications are available from the ACT Consortium:
a. Safety data collection tools for real-world reporting: http://www.actconsortium.org/publications.php/96/safety-data-collection-tools-for-real-world-reporting.html (French version also available here.)
b. Safety webinar: http://www.actconsortium.org/pages/webinars.html
c. Safety animation: https://vimeo.com/143108817
d. ACTc Publications relating to safety methods:
'How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials'
http://www.actconsortium.org/publications.php/73/how-experiences-become-data-the-process-of-eliciting-adverse-event-medical-history-and-concomitant-m.html
'Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data'
http://www.actconsortium.org/publications.php/17/evaluating-harm-associated-with-anti-malarial-drugs-a-survey-of-methods-used-by-clinical-researchers.html
'Designing adverse event forms for real-world reporting: Participatory research in Uganda'
http://www.actconsortium.org/publications.php/45/designing-adverse-event-forms-for-real-world-reporting-participatory-research-in-uganda.html
'Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report'
http://www.actconsortium.org/publications.php/52/eliciting-harms-data-from-trial-participants-how-perceptions-of-illness-and-treatment-mediate-recogn.html
'Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients'
http://www.actconsortium.org/publications.php/56/interaction-between-artemether-lumefantrine-and-nevirapine-based-antiretroviral-therapy-in-hiv-1-inf
'The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients'
http://www.actconsortium.org/publications.php/162/the-interaction-between-artemether-lumefantrine-and-lopinavirritonavir-based-antiretroviral-therapy-.html
'“Every drug goes to treat its own disease…” - A qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania'
http://www.actconsortium.org/publications.php/118/ldquoevery-drug-goes-to-treat-its-own-diseasehelliprdquo-a-qualitative-study-of-perceptions-and-expe.html
'Neuroauditory toxicity of artemisinin combination therapies—Have safety concerns been addressed?'
http://www.actconsortium.org/publications.php/97/neuroauditory-toxicity-of-artemisinin-combination-therapiesmdashhave-safety-concerns-been-addressed.html
''… in the project they really care for us': meaning and experiences of participating in a clinical study of first-line treatment for malaria and HIV in Tanzanian adults'
http://www.actconsortium.org/publications.php/26/hellip-in-the-project-they-really-care-for-us-meaning-and-experiences-of-participating-in-a-clinical
e. Quality Outputs:
'Degradation of Artemisinin-Based Combination Therapies Under Tropical Conditions'
http://www.actconsortium.org/publications.php/167/degradation-of-artemisinin-based-combination-therapies-under-tropical-conditions.html
'Fake anti-malarials: start with the facts'
http://www.actconsortium.org/publications.php/164/fake-anti-malarials-start-with-the-facts.html
'Quality of artemisinin-based combination formulations for Malaria treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria'
http://www.actconsortium.org/publications.php/128/quality-of-artemisinin-based-combination-formulations-for-malaria-treatment-prevalence-and-risk-fact.html
'Quality of artemisinin-containing antimalarials in Tanzania’s private sector— Results from a nationally representative outlet survey'
http://www.actconsortium.org/publications.php/124/quality-of-artemisinin-containing-antimalarials-in-tanzaniarsquos-private-sectormdash-results-from-a.html
'Quality of antimalarials at the epicenter of antimalarial drug resistance: Results from an overt and mystery client survey in Cambodia'
http://www.actconsortium.org/publications.php/125/quality-of-antimalarials-at-the-epicenter-of-antimalarial-drug-resistance-results-from-an-overt-and-.html
'Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa'
http://www.actconsortium.org/publications.php/40/poor-quality-antimalarial-drugs-in-southeast-asia-and-sub-saharan-africa.html
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
http://www.actconsortium.org/publications.php/50/poor-quality-vital-anti-malarials-in-africa-an-urgent-neglected-public-health-priority
'Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries'
http://www.actconsortium.org/publications.php/58/poor-quality-drugs-grand-challenges-in-high-throughput-detection-countrywide-sampling-and-forensics-.html
'Antimalarial drug quality: methods to detect suspect drugs'
http://www.actconsortium.org/publications.php/71/antimalarial-drug-quality-methods-to-detect-suspect-drugs.html